Articles & courses

ArticlesShow all 40
🟠 Aspirin (Acetylsalicylic acid)

…gastrointestinal disorders. Patients with severe kidney disease (glomerular filtration rate < 30 mL/min). Patients with mild to moderate heart failure, kidney or liver disease…

Preeclampsia and Hypertensive Pregnancy Disorders as Future Cardiovascular Risk

…complications. Seizures in a patient with preeclampsia indicate eclampsia. Postpartum disease is clinically important. Hypertension is most frequent in women who had antenatal hypertensive disorders…

Pulmonary Hypertension: Classification and Treatment Principles

…distinct and uncommon form of precapillary PH. It is defined haemodynamically by precapillary PH in the absence of CTEPH, lung disease, or another explanatory cause…

Cardiac amyloidosis

…of increasing frequency of hospitalizations and visits for heart failure without disease recognition in the 3 years preceding diagnosis is also a notable red flag…

CME: How dietary fat affects coronary arteries, LDL cholesterol and body weight

…completely different. It took roughly 50 years for researchers to finally conclude that high cholesterol levels caused coronary artery disease and atherosclerosis in general. This…

Liver parameters

…and the speed of the course. An AST/ALT ratio 2 with moderately raised values suggests alcohol related liver disease; a ratio < 1 suggests…

Inclisiran and Emerging Lipid-Lowering Agents

…when additional LDL C reduction is required, including in patients with atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolaemia. The broader therapeutic principle is that…

🟠 Tricuspid valve

…regurgitation Jet size < 5cm² 5 10 cm² 10 cm² size vena cava inferior < 2,1 cm and compressible in between 2,1 cm…

Bempedoic Acid: Evidence and Clinical Use

…therapy 18% Fixed dose combination with ezetimibe 38% Pooled analyses across different background therapies 17%–25% In patients with atherosclerotic vascular disease or familial hypercholesterolaemia…

Ezetimibe: Place in Therapy and Expected LDL-C Reduction

…acid is recommended in the relevant guideline setting; combination with a PCSK9 inhibitor is also described for high risk patients with atherosclerotic peripheral arterial disease…

Media

No matches.

Tests

Tools